On January 16, the FDAs CDER issued a warning letter to a compounding pharmacy following an inspection conducted from May 12 through June 9, 2025, at the firms facility in Kennett Square, Pennsylvania
It particularly impacts areas affected by growth hormone, including muscles, bones, skin, and internal organs
Potential benefits include improved blood sugar control, reduced appetite, and substantial fat loss when combined with dietary changes and physical activity
Retatrutides triple receptor action is unique among current weight loss medications
It is recommended that patients remain on a maintenance dose to curb cravings and maintain the new weight